Role of the APOB gene polymorphism (c.12669G>A, p. Gln4154Lys) in coronary artery disease in the Indian Punjabi population

Balkan Journal of Medical Genetics

Volumn 14, Issue 2, 2011, Pages 35-40

  Sharma, R ^a   Mahajan, M ^b   Singh, B ^a   Singh, G ^a   Singh, P ^a  

^a GURU NANAK DEV UNIVERSITY   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Apolipoprotein B (apoB); Coronary artery disease (CAD); Polymorphism

Indexed keywords

APOLIPOPROTEIN B; CARBONYL DERIVATIVE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; INDIAN; LIPID BLOOD LEVEL; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 83655172761     PISSN: 13110160     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10034-011-0045-9     Document Type: Article

References (26)

1. Walldius G, Jungner I, Holmes I, Aastveit A, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-1 and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001; 358(9298): 2026-2033. (Pubitemid 34084825)
2. Sniderman AD, Lamarche B, Tilley J. Hypertriglyceridemic hyperapoB in Type 2 diabetes. Diabetes Care. 2002; 25(3): 579-582. (Pubitemid 41103357)
3. Sniderman AD, Furberg CD, Keech A. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet. 2003; 361(9359): 777-780. (Pubitemid 36293636)
4. Sharma R, Singh B, Mahajan M, Ravi Kant M. Age and sex: important determinants in affecting the levels of serum apolipoprotein B and A1 in Indian population. The Internet J Cardiovasc Res. 2006; 3(1).
5. Sharma R, Singh B, Mahajan M. Small dense LDL particles in relation to LDL oxidation in normolipidemic CAD patients. The Internet J Cardiovasc Res. 2011; 7(2).
6. Chan L, VanTuinnen P, Ledbetter DH. The human apolipoprotein B-100 gene: a highly polymorphic gene that maps to the short arm of chromosome 2. Biochem Biophys Res Commun.1985; 133(1): 248-255. (Pubitemid 16155353)
7. Shoulders CC, Myant NB, Sidoli A, Rodriguez JC, Cortese C, Baralle FE, Cortese R. Molecular cloning of human LDL apolipoprotein B cDNA: evidence for more than one year per haploid genome. Atherosclerosis. 1985; 58(1-3): 277-292.
8. Hegele RA, Huang L, Herbert PN, Blum CB, Buring JE, Hennekens CH, Breslow JL. Apolipoprotein gene polymorphism associated with myocardial infarction. N Engl J Med. 1986; 315(24): 1509-1515. (Pubitemid 17052148)
9. Genest JJ, Ordovas JM, McNamara JR, Robbins AM, Meade T, Cohn SD. DNA polymorphism of the apoB gene in patients with premature CAD. Atherosclerosis. 1990; 82(1-2): 7-17.
10. Renges HH, Wile DB, McKeigue PM, Marmot MG, Humphries SE. Apo B gene polymorphisms are associated with lipid levels in men of South Asian descent. Atherosclerosis. 1991; 91(3): 267-275.
11. Scartezinin M, Zago MA, Chautard-Freire-Maia EA, Pazin-Filho A, Marin-Neto JA, Hotta JKS. The X-X-/E+E+ genotype of the XbaI/EcoR1 polymorphisms of the apolipoprotein B gene as a marker of coronary artery disease in a Brazilian sample. Braz J Med Biol Res. 2003; 36(3): 369-375. (Pubitemid 36442987)
12. Mustafina OE, Novikova LB, Nasibullin TR, Kolchina EM, Tuktarova IA. An analysis of association between the apolipoprotein B gene EcoR1 polymorphism and ischemic stroke. Zh Nevrol Psikhiatr Im SS Korsa-kova. 2006; 17: 66-70.
13. Padmaja N, Ravindra Kumar M, Adithan C. Association of polymorphisms in apolipoprotein A1 and apolipoprotein B genes with lipid profile in Tamilian population. Indian Heart J. 2009; 61(1): 51-54.
14. Burstein M, Scholnick HR, Morfin RJ. Estimation of high density lipoprotein cholesterol. J Lipid Res. 1970; 19(6): 583-593.
15. Zlatkis G, Zak B, Boyle A. A new method for the direct estimation of cholesterol. J Lab Clin Med. 1953; 41(3): 486-489.
16. McGowan MW, Artiss JD, Strandberg DR, Zak BA. Peroxidase coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983; 29(3): 438-452.
17. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density cholesterol in plasma, without the use of preparative centrifuge. Clin Chem. 1972; 18(6): 499-502.
18. Wieland H, Seidel D. A simple specific method for precipitation of low density lipoproteins. J Lipid Res. 1983; 24(7): 904-909. (Pubitemid 13015571)
19. Yan LJ, Traber MG, Packer L. Spectrophotometric method for determination of carbonyl in oxidatively modified apolipoprotein B of human low density lipoprotein. Anal Biochem. 1995; 228(2): 349-351.
20. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978; 52: 302-310.
21. Lowry OH, Rosebrough NJ, Farr AI, Randal RJ. Protein measurement with Folin-phenol reagent. J Biol Chem. 1951; 193(1): 265-275.
22. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2001.
23. Chiodini BD, Barlera S, Franzosi MG, Beceiro VL, Introna M, Tognoni G. ApoB gene polymorphism and coronary artery disease: a meta-analysis. Atherosclerosis. 2003; 167(2): 355-366. (Pubitemid 36773535)
24. Puri RD, Tewari S, Sinha N, Ramesh V, Khan F, Singh VP, Aggarwal S. Polymorphisms in apoB-100 gene. Indian Heart J. 203; 55(1): 60-64.
25. Regnstrom J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 1992; 339(8803): 1183-1186.
26. Van de Vijver LPL, Kardinaal AFM, Duyvenvoorde WV, Kruijssen DACM, Grobbe DE, Poppel GV, Princen HMG. LDL oxidation and extent of coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 198; 18(2): 193-199.